Cancer Drug Resistance: review time and acceptance speed
ISSN 2578-532X · Biochemistry, Genetics and Molecular Biology
Half of the articles Cancer Drug Resistance accepted in 2025 were accepted within 96 days of submission (n = 63); the middle half took 69–117 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Cancer Drug Resistance take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2025 | 63 | 69 | 96 | 117 | — | 0.0% | 100% |
| 2024 | 57 | 75 | 97 | 125 | — | 0.0% | 100% |
| 2022 | 63 | 74 | 89 | 114 | — | 0.0% | 98% |
| 2020 | 60 | 50 | 66 | 98 | — | 1.7% | 98% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Distribution in 2025
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 1 | 1.6% |
| 30–59 | 12 | 19.0% |
| 60–89 | 13 | 20.6% |
| 90–119 | 23 | 36.5% |
| 120–149 | 7 | 11.1% |
| 150–179 | 5 | 7.9% |
| 180–209 | 2 | 3.2% |
| 210–239 | 0 | 0.0% |
| 240–269 | 0 | 0.0% |
| 270–299 | 0 | 0.0% |
| 300–329 | 0 | 0.0% |
| 330–359 | 0 | 0.0% |
| 360+ | 0 | 0.0% |
From acceptance to online publication
After acceptance, half of the 2025 articles appeared online within 12 days (middle half 7–23 days, n = 63).
From submission to online publication, the median was 107 days (middle half 84–137 days, n = 63).
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Open access (not listed in DOAJ). No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.
OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | No |
|---|---|
| Articles indexed for MEDLINE in 2025 | None found (the journal may be in PubMed through PubMed Central instead) |
| Retractions | 0 retracted articles among 308 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 0.0% of 2025 articles |
| Publication volume | 71 articles added to PubMed in 2025 (+22% vs 2024). |
Topics and scope
- Cancer Immunotherapy and Biomarkers (9% of indexed topics)
- Cancer Cells and Metastasis (7% of indexed topics)
- Cancer Genomics and Diagnostics (7% of indexed topics)
- MicroRNA in disease regulation (6% of indexed topics)
- Epigenetics and DNA Methylation (5% of indexed topics)
- Cancer, Hypoxia, and Metabolism (5% of indexed topics)
Biochemistry, Genetics and Molecular Biology journalsMedicine journalsMolecular Biology journalsOncology journals
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Cancer Drug Resistance, 96 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Translational Oncology | 148 (2025, n = 375) | $3,880 | — | Yes | No |
| Cellular Oncology | 117 (2025, n = 105) | $2,380 | — | Yes | Yes |
| Molecular Oncology | 153 (2025, n = 193) | $4,730 | $3,784 (6 payments) | Yes | Yes |
| Cancer Research Communications | 140 (2025, n = 192) | $2,550 | $2,503 (12 payments) | Yes | Yes |
| Cancers | 38 (2025, n = 3,955) | ≈$3,499 | $3,064 (462 payments) | No | No |
| Clinical and Translational Medicine | 116 (2025, n = 313) | $3,640 | $3,103 (6 payments) | Yes | Yes |
| Exploration of Targeted Anti-tumor Therapy | 97 (2025, n = 65) | $2,000 | — | Yes | No |
| Journal of Translational Medicine | 93 (2025, n = 1,502) | $4,090 | $3,266 (20 payments) | Yes | Yes |
No journals match these filters.
Frequently asked questions
How long does Cancer Drug Resistance take to accept a paper?
Half of the articles Cancer Drug Resistance accepted in 2025 were accepted within 96 days of submission (n = 63); the middle half took 69–117 days. Based on dates in PubMed for accepted articles only.
How long after acceptance are Cancer Drug Resistance articles published online?
Half of the articles accepted in 2025 appeared online within 12 days of acceptance (n = 63).
Does Cancer Drug Resistance charge an article processing charge (APC)?
No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.
Sources and method
Journal identity: ISSN-L 2578-532X; NLM ID 101738710; OpenAlex record. Speed figures use 63 articles accepted in 2025 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.